DE VINCENTIS, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 4.708
NA - Nord America 776
EU - Europa 410
SA - Sud America 171
AF - Africa 26
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.103
Nazione #
SG - Singapore 3.951
US - Stati Uniti d'America 740
CN - Cina 390
HK - Hong Kong 215
BR - Brasile 135
IT - Italia 130
GB - Regno Unito 91
VN - Vietnam 67
DE - Germania 59
IN - India 28
CA - Canada 23
NL - Olanda 22
AR - Argentina 17
CZ - Repubblica Ceca 17
FI - Finlandia 17
FR - Francia 16
PL - Polonia 13
ID - Indonesia 11
MX - Messico 11
TR - Turchia 11
AU - Australia 10
JP - Giappone 10
EC - Ecuador 9
PT - Portogallo 8
ZA - Sudafrica 8
EG - Egitto 6
UA - Ucraina 6
ES - Italia 5
RO - Romania 5
KE - Kenya 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
SE - Svezia 3
AT - Austria 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BY - Bielorussia 2
CH - Svizzera 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
PE - Perù 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CO - Colombia 1
DZ - Algeria 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GN - Guinea 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
IS - Islanda 1
JO - Giordania 1
KI - Kiribati 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MS - Montserrat 1
MU - Mauritius 1
NO - Norvegia 1
PY - Paraguay 1
RS - Serbia 1
SL - Sierra Leone 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 6.103
Città #
Singapore 285
Hong Kong 213
Hefei 183
Ashburn 162
Boardman 90
Dallas 84
Beijing 82
Rome 67
London 65
Shanghai 58
Munich 39
Ho Chi Minh City 32
Los Angeles 31
Council Bluffs 29
New York 19
Chicago 18
San Francisco 17
Amsterdam 16
Brno 16
Turku 15
Hanoi 14
Boston 13
São Paulo 13
Pune 11
Santa Clara 11
Washington 11
Brooklyn 10
Mexico City 10
Seattle 10
Toronto 10
Warsaw 10
Lisbon 8
Paris 8
Tokyo 8
Boydton 7
Montreal 7
Redmond 7
Cairo 6
Guangzhou 6
Bucharest 5
Canberra 5
Chennai 5
Manchester 5
Milan 5
Rio de Janeiro 5
Charlotte 4
Johannesburg 4
Kochi 4
Nairobi 4
Trieste 4
Bedford 3
Campinas 3
Guayaquil 3
Haiphong 3
Helena 3
Melbourne 3
Perugia 3
Phoenix 3
Poplar 3
Quito 3
Salvador 3
San Jose 3
Shenzhen 3
Ankara 2
Ascoli Piceno 2
Atlanta 2
Belo Horizonte 2
Brasília 2
Buffalo 2
Central 2
Cervignano del Friuli 2
Curitiba 2
Da Nang 2
Denver 2
Goiânia 2
Helsinki 2
Jakarta 2
José C. Paz 2
Latina 2
Lima 2
Lubbock 2
Markham 2
Milwaukee 2
Minsk 2
Montevideo 2
Nam Định 2
Nanyang 2
Naples 2
New Port Richey 2
Newark 2
Rimini 2
Rio Grande 2
Riyadh 2
Secaucus 2
Stockholm 2
Suffern 2
Sydney 2
São Leopoldo 2
Taranto 2
Tupã 2
Totale 1.864
Nome #
Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management 212
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 206
Chronic cough in adults: recommendations from an Italian intersociety consensus 204
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 200
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 191
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 189
A Functional and Immunologic Point of View on Corneal Endothelial Transplantation: A Systematic Review and Meta-Analysis 182
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 182
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 180
Assessment of liver function by the exhaled breath-print during chronic liver disease 177
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 177
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 174
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 169
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 135
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 111
Orthogeriatric co-management for the care of older subjects with hip fracture: recommendations from an Italian intersociety consensus 110
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 108
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 102
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 99
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 94
A challenging alfa-fetoprotein in a cirrhotic patient 92
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 89
Breathprinting of liver diseases 88
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 88
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 87
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 87
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 87
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 86
ALT levels are associated with metabolic parameters and age in a large real-life population. 86
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 84
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 83
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 82
Return to Sport after Anatomic and Reverse Total Shoulder Arthroplasty in Elderly Patients: A Systematic Review and Meta-Analysis 80
Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards 76
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 73
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 69
Essays on quality of therapy and impact of comorbidities in older hospitalized subjects 65
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 58
Length of Hospital Stay after Total Knee Arthroplasty: A Correlation Study on 1200 Patients 49
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 49
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 46
Return to Sport Activity in the Elderly Patients after Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis 42
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 41
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 39
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 36
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 36
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 34
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 34
Predicting risk of declining functional ability in community-dwelling older people 33
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 33
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 32
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 32
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 32
Preoperative and Perioperative Predictors of Length of Hospital Stay after Primary Total Hip Arthroplasty-Our Experience on 743 Cases 31
Hepatic complications of bariatric surgery : the reverse side of the coin 30
Prevalence, clinical characteristics, and disease burden of chronic cough in Italy: a cross-sectional study 28
Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy 28
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 28
E-nose discriminative ability within a highly homogeneous sample of respiratory diseases 28
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 27
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 27
NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY 27
The authors reply 27
Reply 26
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 26
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 26
Screening of obstructive sleep apnea syndrome by electronic-nose analysis of volatile organic compounds 26
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver 26
Sleep disorders during the COVID-19 pandemic: Results from the second phase of web-based EPICOVID19 study 25
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 25
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 25
Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study 25
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis 25
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 24
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 24
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 24
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 24
Clinical outcomes and phenotypes of respiratory failure in older subjects admitted to an acute care geriatric hospital ward 23
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 23
Neurotrophic keratopathy: pros and cons of current treatments 23
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 22
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 22
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 21
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis 20
Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival 20
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 20
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment 20
Reply 19
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 19
Genetic variants in the MTHFR are not associated with fatty liver disease. 18
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 17
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 17
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 12
Totale 6.178
Categoria #
all - tutte 38.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 0 0 10 0 1 4 0 2 54 0 0 103
2022/202399 1 1 8 2 10 4 36 9 5 7 16 0
2023/2024316 11 27 15 36 39 120 0 10 4 16 12 26
2024/20254.616 57 25 87 19 75 96 87 25 217 291 1.633 2.004
2025/2026973 295 148 222 308 0 0 0 0 0 0 0 0
Totale 6.178